Comparison of Immunogenicity of Cood-Cotd, CfaB-st-CfaE, and Cssa-Cssb-ltb Chimeric Proteins and Their Chitosan Nanoparticles Against ETEC in an Animal Model
The Protein Journal · 09.06.2026 · 45 (4) · 576-588
DOI: 10.1007/s10930-026-10342-8 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Protein Journal, online erschienen am 09.06.2026. Verfasst von Behnam Zarei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, TeMS.C, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Chitosan, Enterotoxigenic Escherichia coli, Nanoparticles, Recombinant Fusion Proteins. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, TeMS.C, Islamic Azad University, Tehran, Iran.
- Applied Microbiology Research Center, Biomedicine Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Vanak Sq.Molasadra St, P.O. Box 19395, Iran. jafar.amani@gmail.com.
Zitieren
APA
Zarei, B., Amani, J., & Haghighat, S. (2026). Comparison of Immunogenicity of Cood-Cotd, CfaB-st-CfaE, and Cssa-Cssb-ltb Chimeric Proteins and Their Chitosan Nanoparticles Against ETEC in an Animal Model. The Protein Journal, 45(4), 576-588. https://doi.org/10.1007/s10930-026-10342-8
Vancouver
Zarei B, Amani J, Haghighat S. Comparison of Immunogenicity of Cood-Cotd, CfaB-st-CfaE, and Cssa-Cssb-ltb Chimeric Proteins and Their Chitosan Nanoparticles Against ETEC in an Animal Model. The Protein Journal. 2026;45(4):576-588. doi:10.1007/s10930-026-10342-8
BibTeX
@article{Zarei2026,
author = {Zarei, Behnam and Amani, Jafar and Haghighat, Setareh},
title = {Comparison of Immunogenicity of Cood-Cotd, CfaB-st-CfaE, and Cssa-Cssb-ltb Chimeric Proteins and Their Chitosan Nanoparticles Against ETEC in an Animal Model},
journal = {The Protein Journal},
year = {2026},
volume = {45},
number = {4},
pages = {576--588},
doi = {10.1007/s10930-026-10342-8}
}
EUVIMED